Background. Diabetes is a major risk factor for the development of kidney disease. We aimed to determine the prevalence of albuminuria and chronic kidney disease (CKD) in Chinese subjects with diabetes and pre-diabetes and the risk factors for kidney disease.
Introduction
Diabetes has been a big public health problem in China for the last 10 years and imposes heavy economic burdens to Chinese patients [1, 2] . The micro-and macrovascular complications of diabetes are the major causes for morbidity and mortality. However, there is less evidence to address the prevalence of diabetes complications in the Chinese pre-diabetes patient population. In the previous Shanghai Diabetes Studies (SHDS) [2] , the prevalence of diabetes and impaired glucose regulation (IGR) was high in the Chinese urban population. Over a 5-year period, we recruited nearly 2000 participants from SHDS for the screening of chronic diabetes complications in type 2 diabetes and IGR.
Routine screening for albuminuria is recommended for diabetes care [3] , as microalbuminuria has been suggested to be a predictor of overt diabetic nephropathy. However, in recent studies, overt nephropathy was only found in 30-45% of microalbuminuric patients after a 10-year followup [4, 5] and over half of patients with microalbuminuria may revert to normoalbuminuria [6] . These findings raise questions regarding the usefulness of the predictive value of microalbuminuria.
As a manifestation of kidney damage, albuminuria is a component of chronic kidney disease (CKD). CKD is now used as a predictor for cardiovascular disease (CVD) and end-stage renal disease [7] [8] [9] . As more than 95% of CKD was reported to occur in patients with diabetes and hypertension [10] , it is crucial to detect early CKD in diabetes patients in order to prevent renal insufficiency and decrease cardiovascular mortality associated with CKD. The use of formulae for estimated glomerular filtration rate (eGFR) is now recommended for screening the prevalence of CKD, as the measurement of true GFR is time consuming and expensive. However, few studies concerned the GFR of Kidney disease in Chinese diabetes and pre-diabetes diabetic patients in China. In addition, the association of CKD with pre-diabetes, such as impaired glucose tolerance (IGT), remains to be elucidated. Therefore, our aim was to determine the prevalence and risk factors of albuminuria and CKD in the Chinese population with type 2 diabetes and IGR. Furthermore, we compared the decrease in renal function-in the presence of albuminuria-in subjects with type 2 diabetes, impaired glucose regulation and normal glucose tolerance.
Subjects and methods

Study population
The purpose of the Shanghai Diabetic Complications Study (SHDCS) was to screen for microvascular and macrovascular complications in Chinese subjects with diabetes and pre-diabetes. It was the continued researches of the Shanghai Diabetes Study (SHDS). Since 1996, 5994 individuals aged >15 years were enrolled in the SHDS from two communities, Huayang and Caoyang [2] . Among the analysed population (n = 5628, >20 years), 639 individuals were diagnosed as diabetic, and another 661 subjects were impaired glucose regulation (IGR) by the first oral glucose tolerance test (OGTT). Most of the diabetic and pre-diabetic patients were recruited again in the SHDCS from March 2005 to February 2006 and received a second OGTT, as shown in the flow chart ( Figure 1 ). The other 2865 subjects were recruited from the Tangqiao and Changfeng community from June 2005 to May 2007, which were located adjacent to the previous two communities. Unlike the patients from the SHDS, these subjects were enrolled according to any of the following criteria, including familial diabetes history, hypertension, overweight/obesity, dyslipidaemia, cardiovascular disease/stroke and a gestational history of large babies (for women). Over 40% of the subjects from Tangqiao and Changfeng were diagnosed as diabetes and pre-diabetes by OGTT. We combined the two surveys together in order to investigate the status quo of chronic complications in Chinese patients with type 2 diabetes and pre-diabetes. Subjects with type 1 diabetes, with acute renal failure or receiving dialysis were excluded. Informed consent was obtained from all participants. All the protocols were approved by the local ethics committees.
Anthropometric measurements
Physical examination included measurement of height, weight, waist circumference, hip circumference, femoral circumference and blood pressure. Blood pressure was taken three times using a standard mercury sphygmomanometer and then averaged. Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg [11] (WHO 1999), or current use of blood pressure-lowering medication was used to define hypertension. Body mass index (BMI) was calculated as weight divided by height squared (kg/m 2 ). Obesity was defined as BMI ≥30 kg/m 2 [12] (WHO 1997). The waist-to-hip ratio was calculated as the ratio of the waist circumference to the hip circumference. Other information such as education degree and living habits was also collected.
Laboratory measurements and definitions
After a fasting venous blood sample was collected, each participant received a 75 g oral glucose tolerance test, except for those with a validated history of diabetes mellitus. Plasma glucose levels were measured using the glucose oxidase method. Glycated haemoglobin (HbA 1c ) was estimated by high-pressure liquid chromatography using an analyser (HLC-723G7, Tosoh Corporation, Japan). Serum urea nitrogen, creatinine, uric acid and lipid profiles, including measurements of total cholesterol, triacylglycerol, high density lipoprotein [HDL]-cholesterol and low-density lipoprotein [LDL]-cholesterol, were measured on a Hitachi 7600 analyser using an enzymatic assay. Hypersensitive C-reactive protein was examined by nephelometry (Vista CardioPhase R high sensitivity CRP, Dade Behring, Japan). First morning urine was collected once a month for 3 months. Urinary albumin was determined on a Dade Behring BN II analyser by nephelometry (N antiserum to Human Albumin Assay, Dade Behring). Urinary creatinine concentration was measured on a Hitachi 7600 analyser using the sarcosine oxidase-PAP method. All control values were consistent with the standard recommended by the Shanghai Clinical Testing Center.
Diabetes and impaired glucose regulation were diagnosed according to the standard set by the American Diabetes Association (ADA) in 1997 [13] . IGR can be classified into three subgroups according to the level of fasting plasma glucose (FPG) and 2-h postprandial plasma glucose (2hPG): isolated impaired fasting glucose (isolated IFG, 6.1 mmol/L ≤ FPG < 7.0 mmol/L and 2hPG < 7.8 mmol/L), isolated IGT (FPG < 6.1 mmol/L and 7.8 mmol/L ≤ 2hPG < 11.1 mmol/L) and combined IGT (6.1 mmol/L ≤ FPG< 7.0 mmol/L and 7.8 mmol/L ≤ 2hPG < 11.1 mmol/L). Dyslipidaemia was defined as an elevation of serum cholesterol (≥6.1 mmol/L) and/or triacylglycerol (≥2.26 mmol/L), or an elevated LDL-cholesterol ≥ 4.14 mmol/L or a decreased HDL-cholesterol < 1.0 mmol/L, according to the American National Cholesterol Education Program (Adult Treatment Panel III) [14] . CVD was defined as coronary heart disease and cerebrovascular disease (stroke).
Albuminuria. Urinary albumin-to-creatinine ratio (ACR) was computed, and albuminuria was defined as an ACR of 30 mg/g or higher, with microalbuminuria defined as an ACR of 30-299 mg/g, and macroalbuminuria defined as an ACR of 300 mg/g or higher. All albuminuria analyses excluded women who were pregnant or menstruating.
Chronic Kidney Disease. Chronic kidney disease was defined as either kidney damage or GFR <60 mL/min/1.73 m 2 . The GFR was estimated using the Modification of Diet in Renal Disease (MDRD) Study formula [15] as follows: 186 × [serum creatinine (mg/dL)] −1.154 × (age) −0.203 × (0.742 if female). The values of eGFR that exceeded 200 mL/min/1.73 m 2 were truncated at that level and individuals were classified using standard criteria. Individuals with eGFR <15 mL/min/1.73 m 2 (CKD stage 5) [7] were excluded because estimates of this stage were likely to be unreliable due to the small number of individuals and the likelihood that many of these individuals will be ill or receiving dialysis and therefore would have a low response rate.
The CKD stages were categorized based on the classification system established by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative [7] . The CKD stages were defined as follows: Stage 1, persistent albuminuria with an estimated GFR higher than 90 mL/min/1.73 m 2 ; Stage 2, persistent albuminuria with an estimated GFR of 60-89 mL/min/1.73 m 2 ; Stage 3, an estimated GFR of 30-59 mL/min/ 1.73 m 2 ; and Stage 4, an estimated GFR of 15-29 mL/min/ 1.73 m 2 . Stages 3-4 of CKD (eGFR < 60 mL/min/ 1.73 m 2 ) were defined as renal insufficiency.
Statistical analysis
All analyses were performed using SPSS software version 15.0. Normally distributed and continuous variables were expressed as mean ± standard deviation (SD), and non-normally distributed variables were presented as medians (quartiles 25% and 75%). To assess the difference among normal glucose tolerance (NGT), IGR and diabetes with regard to quantitative data, a one-way ANOVA with SNK analysis was used. Analysis of covariance was applied to adjust comparisons among NGT, IGR and diabetes for imbalances in age between these groups. A Kruskal-Wallis H or χ 2 test was used for comparisons of non-normally distributed data. Trends across different glycaemic statuses were determined using the Wald chi-square test for trend. Binary logistic regression was performed to analyse the contribution of the risk factors to the presence of albuminuria and CKD.
Polynominal regression was used to calculate the trends of eGFR with the increment of ACR. P < 0.05 was considered significant (two tailed).
Results
Clinical characteristics of the study population
The SHDCS analysed 3714 subjects. These comprised 1385 males and 2329 females, with an average age of 64.4 ± 11.4 years. The prevalence of albuminuria and CKD were 21.9% and 24.4%, respectively. These individuals were classified into three groups based on a 75 g oral glucose tolerance test: NGT, IGR and diabetes (Table 1) . Of the subjects, 25% (n = 930) had type 2 diabetes, among which 56.7% were known to have diabetes. Over 60% of subjects with IGR were impaired glucose tolerance (IGT). The frequencies of subjects who were smokers and had a high level of education were similar among subjects with NGT, IGR and diabetes. The values of age, BMI, waist circumference, waist-to-hip ratio, systolic blood pressure, diastolic blood pressure, HbA 1c , triacylglycerol, C-reactive protein, serum urea nitrogen, serum creatinine and uric acid were significantly higher in diabetes subjects and IGR than those in NGT. The cardiovascular disease and hypertension were much more prevalent in diabetes and those with IGR.
The mean values of total cholesterol in diabetes, IGR and NGT were comparable without difference. The reason for this was that the frequency of the lipid-lowering treatment was 8.7% in diabetic patients, especially in those known diabetes (11.2%), which was significantly higher in IGR subjects (3.9%) and NGT subjects (2.0%). Thus, the total cholesterol level in known diabetes was 4.70 ± 1.09 mmol/L, which was the lowest compared with IGR and NGT (P < 0.01); whereas the total cholesterol level of newly diagnosed diabetes (5.04 ± 1.00 mmol/L) was significantly higher than that of IGR and NGT (P < 0.05).
The diabetes subjects had the highest ACR and eGFR, even adjusted by age. As the values of ACR were nonnormally distributed, ACR was computed into logarithmetic variables. The difference of ACR between IGR and NGT was still significant after adjustment. Analysis of covariance revealed that the eGFR of patients with IGR was significantly higher than NGT after adjusting by age.
After adjusting by age, ACR and eGFR in women were 18.0 mg/g and 94.2 mL/min/1.73 m 2 , respectively, which were significantly higher than those in men (ACR: 10.8 mg/g, P < 0.001; eGFR: 92.8 mL/min/1.73 m 2 , P = 0.016). The frequency of albuminuria in women was 25.4%, which was significantly higher than that in men (16.0%).
Prevalence of albuminuria and CKD
The prevalences of microalbuminuria, macroalbuminuria and CKD in diabetes subjects were 22.8%, 3.4% and 29.6%, respectively, which were significantly higher than those in subjects with NGT (Table 2) . Subjects known to have diabetes, with a mean duration of 7.4 ± 6.6 years, had the highest prevalence of albuminuria and CKD (28.8% and 32.7%, respectively). The prevalence of albuminuria and CKD was similar between subjects with IGR and NGT. In the NGT subjects with hypertension, the prevalence of CKD was significantly higher than those without hypertension (P < 0.01). The prevalence of eGFR <60 mL/min/ 1.73 m 2 , defined as renal insufficiency, was 3.4%, 4.7% and 6.7% in subjects with NGT, IGR and diabetes, respectively (P < 0.001).
With the progression of CKD from Stages 1 to 4, the percentage of subjects with a history of diabetes, hypertension, obesity, central obesity, high cholesterol, high triacylglycerol, CVD and dyslipidaemia increased significantly (all P < 0.05) ( Table 3) .
Risk factors for albuminuria and renal insufficiency
As the subjects with diabetes and hypertension had a higher prevalence of albuminuria and CKD, we analysed the contribution of risk factors such as diabetes, IGR, level of HbA 1c , hypertension, CVD, obesity and various dyslipidaemia to the presence of albuminuria and renal insufficiency (GFR < 60 mL/min/1.73 m 2 ) using the logistic regression. Table 4 , diabetes was an independent risk factor for albuminuria with an odds ratio of 1.22 (1.01-1.47, P = 0.04). In the nondiabetic population, however, the odds ratio of IGR was 0.71 (P = 0.002) for albuminuria after adjusting by age. In order to assess whether the mean level blood glucose contributes to albuminuria and renal insufficiency, we stratified HbA 1c , the marker for glycaemic control, into three levels as follows. Target level of HbA 1c was <6.5%, good control referred to HbA 1c ranging from 6.5% to 7.4% and poorly control was over 7.5%. After adjusting by age, hypertension and CVD, HbA 1c over 7.5% increased the risk for albuminuria with an odds ratio of 1.52 (1.14-2.03, P = 0.004). The odds ratios of hypertension and CVD for albuminuria were 1.23 (1.03-1.47, P = 0.000) and 1.36 (1.09-1.70, P = 0.006), respectively.
Risk factors for albuminuria. As shown in
Risk factors for renal insufficiency.
Neither IGR nor diabetes was a risk factor for renal insufficiency, as shown in Table 5 . However, when eGFR mildly decreased (60-90 mL/min/1.73 m 2 ), diabetes and IGR both exhibited as negative factors with odds ratios of 0.43 (0.36-0.52, P = 0.000) and 0.63 (0.52-0.77, P = 0.000). After adjusting by age, hypertension and CVD, the levels of HbA 1c did not contribute to the risk of renal insufficiency.
Hypertension was the only independent factor for renal insufficiency after age adjustment [OR: 2.55, 95% confidence interval (CI): 1.63-3.98, P = 0.000].
As a result, neither obesity nor various dyslipidaemia (including high cholesterol, high triacylglycerol, high LDLcholesterol and low HDL-cholesterol) was a risk factor for albuminuria and renal insufficiency.
eGFR trends with ACR in diabetes and IGR
To compare the difference in eGFR among subjects with NGT, IGR and diabetes with the increment of urine ACR, we carried out a polynominal regression to estimate the pattern of decreasing eGFR. As shown in Figure 2 , the cubic parabola regression equations of eGFR for diabetes (P = 0.007, R = 0.895) and IGR (P = 0.008, R = 0.892) showed that the eGFR of subjects with an ACR <100 mg/g Step was higher in subjects with diabetes than in those with IGR; in subjects with an ACR ≥ 100 mg/g, the eGFR of subjects with diabetes and IGR decreased rapidly and similarly. However, the eGFR of subjects with NGT was maintained linearly at a normal level (P = 0.01, R = 0.641) and the decrease of eGFR was minimal. In subjects with an ACR ranging from 30 to 100 mg/g, the eGFR level was significantly higher in subjects with diabetes (103.4 mL/ min/1.73 m 2 , 95% CI: 99.7-107.1, P < 0.0001) and IGR (96.4 mL/min/1.73 m 2 , 95% CI: 92.6-100.3, P < 0.01) than in NGT subjects (89.1 mL/min/1.73 m 2 , 95% CI: 86.4-91.9) after age adjustment. In subjects with an ACR ≥ 100 mg/g, the eGFR level was lower in subjects with diabetes (85.6 mL/min/1.73 m 2 , 95% CI: 80.8-90.4, P = 0.833) and IGR (83.1 mL/min/1.73 m 2 , 95% CI: 76.5-89.6, P = 0.418) than in those with NGT (86.3 mL/min/1.73 m 2 , 95% CI: 82.0-90.6), but the differences were not significant after age adjustment.
Discussion
The SHDCS aimed to determine the prevalence of albuminuria and CKD in a large population of Chinese patients with diabetes and IGR. Unlike albuminuria, the measurement of GFR kidney function (alternatively, serum creatinine and or eGFR) was rarely applied as a screening method for kidney disease in Chinese diabetic patients. The high prevalence of CKD in the present study suggested that screening for GFR was necessary for clinical therapy to prevent the endstage kidney disease in diabetes. We also demonstrated the major risk factors associated with albuminuria and renal insufficiency (eGFR < 60 mL/min/1.73 m 2 ), respectively. In our study, the prevalence of albuminuria (26.1%) and CKD (29.6%) was high in a Chinese urban population with type 2 diabetes. Diabetes subjects, especially those known to have diabetes prior to enrolment, had the highest prevalence of albuminuria and CKD compared with those with other glycaemic status. Compared with the recent epidemiological data in Asia [16] [17] [18] [19] , the prevalence of albuminuria in type 2 diabetes subjects was lower in the present study. A major reason for this is that half of the diabetes cases in our study were newly diagnosed, while most of the cases in other studies were known and probably had a longer duration of diabetes. However, as the methods to define eGFR varied and not every study took albuminuria into account, the prevalence of CKD in type 2 diabetes subjects cannot be compared with the recent nationwide epidemiological studies [20] [21] [22] .
Diabetes, obesity, hypertension and dyslipidaemia were demonstrated to be important risk factors for renal dysfunction [23] [24] [25] [26] [27] [28] . Diabetes is characterized by progression from glomerular hyperfiltration to microalbuminuria with abnormal renal permeability to overt proteinuria and loss of GFR. Brancati et al. demonstrated that diabetes mellitus was a strong independent risk factor for end-stage renal disease in a prospective cohort study of men screened for multiple risk factors [23] . However, diabetes mellitus in the study was defined by self-reported use of medication for diabetes at baseline, not by an oral glucose tolerance test. Fox et al. further found that participants with known diabetes at baseline had a two-fold odds of developing CKD (defined as GFR <60 mL/min/1.73 m 2 ), while the risk of CKD among those with newly diagnosed diabetes was no longer significant after adjustment for multiple vascular disease risk factors [26] . However, few studies concerned the relationship of eGFR and ACR with pre-diabetic stages. In the present study, we compared the different patterns of decreasing eGFR with the increment of ACR among diabetes, IGR and NGT. The worsening trends of eGFR with increasing albuminuria in diabetes and IGR patients were similar. The eGFR maintained normal or supranormal until macroalbuminuria occurred and then dropped abruptly. In contrast, the NGT patients showed a slight and linear fall with increasing albuminuria. It seemed that the decrease of eGFR was accelerated in hyperglycaemic patients, including diabetes and IGR. However, other metabolic disorders, such as hypertension, cardiovascular disease, dyslipidaemia, etc., may also affect the change of eGFR. In addition, ageing was also another considerable factor. The rapidly decreased eGFR in hyperglycaemic patients might be closely associated with those metabolic disorders.
The only independent risk factors for renal insufficiency were age and hypertension. The independent risk factors for albuminuria were the same but diabetes and CVD also came out significant in mulitvariate analysis. Thus, the albuminuria in these diabetes patients is related not only to diabetes but also to CVD, possibly associated with endothelial dysfunction [29] .
As a pre-diabetic stage, impaired glucose regulation was an undetermined risk factor for renal insufficiency. However, few previous studies examined the relationship between decreased eGFR and ACR in IGR patients. In the previous studies of diabetic nephropathy among the Pima Indians, GFRs at baseline among those with NGT, IGT and newly diagnosed diabetes were 123, 135 and 143 mL/min, respectively. At follow-up, GFR further increased by 14% in subjects with IGT and by 18% in those with newly diagnosed diabetes, whereas increases were not seen in those with diabetes of longer duration [30] . In the present study, the eGFR of IGR and diabetes patients were maintained in a hyperfiltraition state initially, but decreased rapidly in the presence of macroalbuminuria in a similar manner. However, in analysis for reduced eGFR, IGR was not an independent risk factor, as hypertension and age were the truly determined factors for eGFR. The rapidly decreased eGFR in IGR was associated with the higher concomitancy of hypertension (62.4%), compared with NGT (41.3%). In analysis for albuminuria, the odds ratio of IGR showed a significantly negative effect, which is consistent with that for mild decreased eGFR. It suggested that the GFR in IGR patients was similar to the hyperfiltration state in the early stage of diabetes, a state in which albuminuria had not occurred. IGR is clinically defined as a prediabetic stage, with which the concomitant metabolic disorders were apparently less than those in diabetes. Thus, IGR was not a significant risk factor for albuminuria and renal insufficiency.
To the best of our knowledge, the available crosssectional epidemiology studies rarely reported the relationship of HbA 1c with CKD. The KEEP study [31] demonstrated that participants with CKD who reported having diabetes were unlikely to have met target blood glucose levels. The target blood glucose level they defined was a fasting blood glucose level of <127 mg/dL or a nonfasting blood glucose level of <140 mg/dL. A more recent study demonstrated that HbA 1c was independently associated with albuminuria and renal insufficiency in diabetes patients [32] . In the present study, we examined the serum HbA 1c among all the participants. The target level of HbA 1c <7% is recommended by the medicare standard of ADA 2007 [3] . After adjusting by age, hypertension and CVD, HbA 1c over 7.5%, a state defined as poorly glycaemic control, significantly increased the risk for albuminuria. But the high level of HbA 1c did not influence renal insuffiency. It once again suggested that reduced eGFR was closely associated with hypertension besides hyperglycaemia.
Our study has several strengths, including the large community-based urban population, the highly complete dataset and the centralized assessment of measurements.
Although recent pathological experiments in Pima Indians illustrated that albuminuria may not be an ideal biomarker for nephropathy progression risk in type 2 diabetes [33] , the mechanism of albuminuria and its relationship with GFR loss remain unclear. Screening programmes using a combination of the albumin-to-creatinine ratio and estimated GFR are still recommended. However, there are some limitations in the present study. We used MDRD-estimated GFR rather than a precise measurement of iothalamate clearance to determine renal function. In this case, a much higher prevalence of CKD may be present in the Chinese population with type 2 diabetes and IGR, as the estimated GFR may underestimate the rate of declined GFR [34] . In addition, a follow-up study is required to determine the factors involved in the development of CKD among those prediabetes or newly diagnosed diabetes subjects.
In summary, the prevalence of albuminuria and CKD was high in the Chinese population with type 2 diabetes. Diabetes (especially with a high HbA 1c level >7.5%) and CVD were independent risk factors for albuminuria. Ageing and hypertension were the two important risk factors for renal insufficiency. Although the worsening trends of eGFR were similar in diabetes and IGR subjects, IGR was not a significant risk factor for albuminuria and renal insufficiency, probably for the reason that there were less concomitant metabolic diseases in IGR than in diabetes. Screening for albuminuria and eGFR is highly recommended for patients with diabetes, hypertension and cardiovascular disease to prevent end-stage kidney disease, especially for old people.
